Acetic acid;tris(fluoropalladium(1+));bis((5-methoxy-2-pyridin-2-ylphenyl)-(4-methylphenyl)sulfonylazanide);bis((4-methylphenyl)sulfonyl-(4-methyl-2-pyridin-2-ylphenyl)azanide);bis((4-methylphenyl)sulfonyl-[2-pyridin-2-yl-5-(trifluoromethyl)phenyl]azanide);tris(palladium);hexakis(pyridine)
C150H138F9N18O20Pd6S6-3 — CID 160586582
Data last refreshed: (MolForge compound catalog, from PubChem)
About Acetic acid;tris(fluoropalladium(1+));bis((5-methoxy-2-pyridin-2-ylphenyl)-(4-methylphenyl)sulfonylazanide);bis((4-methylphenyl)sulfonyl-(4-methyl-2-pyridin-2-ylphenyl)azanide);bis((4-methylphenyl)sulfonyl-[2-pyridin-2-yl-5-(trifluoromethyl)phenyl]azanide);tris(palladium);hexakis(pyridine)
Acetic acid;tris(fluoropalladium(1+));bis((5-methoxy-2-pyridin-2-ylphenyl)-(4-methylphenyl)sulfonylazanide);bis((4-methylphenyl)sulfonyl-(4-methyl-2-pyridin-2-ylphenyl)azanide);bis((4-methylphenyl)sulfonyl-[2-pyridin-2-yl-5-(trifluoromethyl)phenyl]azanide);tris(palladium);hexakis(pyridine) (PubChem CID 160586582) has the molecular formula C150H138F9N18O20Pd6S6-3 and a molecular weight of 3514.76 g/mol. Its IUPAC name is acetic acid;tris(fluoropalladium(1+));bis((5-methoxy-2-pyridin-2-ylphenyl)-(4-methylphenyl)sulfonylazanide);bis((4-methylphenyl)sulfonyl-(4-methyl-2-pyridin-2-ylphenyl)azanide);bis((4-methylphenyl)sulfonyl-[2-pyridin-2-yl-5-(trifluoromethyl)phenyl]azanide);tris(palladium);hexakis(pyridine).
Molecular Properties
| Compound Name | Acetic acid;tris(fluoropalladium(1+));bis((5-methoxy-2-pyridin-2-ylphenyl)-(4-methylphenyl)sulfonylazanide);bis((4-methylphenyl)sulfonyl-(4-methyl-2-pyridin-2-ylphenyl)azanide);bis((4-methylphenyl)sulfonyl-[2-pyridin-2-yl-5-(trifluoromethyl)phenyl]azanide);tris(palladium);hexakis(pyridine) |
|---|---|
| PubChem CID | 160586582 |
| Molecular Formula | C150H138F9N18O20Pd6S6-3 |
| Molecular Weight | 3514.76 g/mol |
| Exact Mass | 3509.27 |
| IUPAC Name | acetic acid;tris(fluoropalladium(1+));bis((5-methoxy-2-pyridin-2-ylphenyl)-(4-methylphenyl)sulfonylazanide);bis((4-methylphenyl)sulfonyl-(4-methyl-2-pyridin-2-ylphenyl)azanide);bis((4-methylphenyl)sulfonyl-[2-pyridin-2-yl-5-(trifluoromethyl)phenyl]azanide);tris(palladium);hexakis(pyridine) |
| SMILES | CC(=O)O.CC(=O)O.CC(=O)O.COc1ccc(-c2ccccn2)c([N-]S(=O)(=O)c2ccc(C)cc2)c1.COc1ccc(-c2ccccn2)c([N-]S(=O)(=O)c2ccc(C)cc2)c1.Cc1ccc(S(=O)(=O)[N-]c2cc(C(F)(F)F)ccc2-c2ccccn2)cc1.Cc1ccc(S(=O)(=O)[N-]c2cc(C(F)(F)F)ccc2-c2ccccn2)cc1.Cc1ccc(S(=O)(=O)[N-]c2ccc(C)cc2-c2ccccn2)cc1.Cc1ccc(S(=O)(=O)[N-]c2ccc(C)cc2-c2ccccn2)cc1.F[Pd+].F[Pd+].F[Pd+].[Pd].[Pd].[Pd].c1ccncc1.c1ccncc1.c1ccncc1.c1ccncc1.c1ccncc1.c1ccncc1 |
| InChI | InChI=1S/2C19H14F3N2O2S.2C19H17N2O3S.2C19H17N2O2S.6C5H5N.3C2H4O2.3FH.6Pd/c2*1-13-5-8-15(9-6-13)27(25,26)24-18-12-14(19(20,21)22)7-10-16(18)17-4-2-3-11-23-17;2*1-14-6-9-16(10-7-14)25(22,23)21-19-13-15(24-2)8-11-17(19)18-5-3-4-12-20-18;2*1-14-6-9-16(10-7-14)24(22,23)21-19-11-8-15(2)13-17(19)18-5-3-4-12-20-18;6*1-2-4-6-5-3-1;3*1-2(3)4;;;;;;;;;/h2*2-12H,1H3;2*3-13H,1-2H3;2*3-13H,1-2H3;6*1-5H;3*1H3,(H,3,4);3*1H;;;;;;/q6*-1;;;;;;;;;;;;;;;;3*+2/p-3 |
| InChIKey | MUBHTOUHNSMUKZ-UHFFFAOYSA-K |
| XLogP | 37.39 |
| TPSA | 574.48 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 209 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3514.76 |
| LogP ≤ 5 | 37.39 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 29 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160586582 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.